logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Entecavir Monohydrate CAS 209216-23-9 with Molecular Formula C12H17N5O4

Entecavir Monohydrate CAS 209216-23-9 with Molecular Formula C12H17N5O4

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 209216-23-9

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:

CAS 209216-23-9 Entecavir Monohydrate

,

C12H17N5O4 Entecavir Monohydrate

CAS NO::
209216-23-9
Appearance ::
White Crystalline Powder
Molecular Formula::
C12H17N5O4
Molecular Weight::
295.294
EINECS NO::
606-668-5
MDL NO::
MFCD09754448
CAS NO::
209216-23-9
Appearance ::
White Crystalline Powder
Molecular Formula::
C12H17N5O4
Molecular Weight::
295.294
EINECS NO::
606-668-5
MDL NO::
MFCD09754448
Entecavir Monohydrate CAS 209216-23-9 with Molecular Formula C12H17N5O4

Product Description:

Product Name: Entecavir Monohydrate CAS NO:209216-23-9

 

 

 

 

 

 

 

Synonyms:

2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one, monohydrate;

 

 

 

 

 

 

 

 

 

Chemical & Physical Properties:

Appearance : white crystalline powder

Assay :≥99.0%

Density:1.81 g/cm3

Boiling Point:661.4℃ at 760 mmHg

Flash Point:353.8℃

 

 

 

 

 

 

 

 

 

Entecavir monohydrate is a new type of cyclopentanoylguanosine anti-hepatitis B virus drug. Its pharmacological action is similar to entecavir. It is clinically suitable for active virus replication, continuous increase in serum transaminase ALT or liver histology showing active lesions Treatment of chronic adult hepatitis B.

Entecavir has a strong antiviral ability, and the incidence of drug resistance is low in long-term use. It may have a direct inhibitory effect on cccDNA in liver cells. It can effectively treat chronic hepatitis B and has a better curative effect than lamivudine.

 

 

 

 

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

 

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.